Related Experiment Video
Updated: May 3, 2026
11:35
The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool
Published on: June 30, 2014
58.9K
The clinical course of multiple sclerosis
Christian Confavreux1, Sandra Vukusic1
1Service de Neurologie A, EDMUS Coordinating Center, INSERM U 842, Hôpital Neurologique Pierre Wertheimer, Lyon, France.
Handbook of Clinical Neurology
|February 11, 2014
Summary
Understanding multiple sclerosis (MS) epidemiology and natural history is crucial for informed care decisions. Reliable studies, using population-based designs and rigorous methods, are essential for accurate insights into MS progression and prognosis.
Area of Science:
- Neurology
- Epidemiology
- Clinical Research
Background:
- Accurate knowledge of multiple sclerosis (MS) epidemiology and natural history is vital for patient and practitioner decision-making.
- High-quality studies with robust methodologies are fundamental for reliable MS data.
- Understanding MS requires adherence to standards like population-based ascertainment, large cohorts, long-term prospective follow-up, and advanced statistical analysis.
Purpose of the Study:
- To review epidemiologic and natural history data relevant to clinical MS issues.
- To examine factors influencing MS recovery, disease progression, disability accumulation, and prognosis.
- To explore the impact of life events on the clinical course of MS.
Main Methods:
- Review of existing epidemiologic and natural history studies on MS.
- Analysis of data focusing on clinical outcomes such as recovery, attacks, progression, and disability.
- Consideration of confounding factors including disease-modifying therapy and age at onset.
Main Results:
- The accumulation of disability in MS may largely be an age-related process, independent of clinical subtype.
- Studies provide insights into the likelihood and timing of recovery, subsequent attacks, and disability progression.
- The impact of various life events on MS clinical course is examined.
Conclusions:
- Informed clinical decisions in MS rely on high-quality epidemiologic and natural history research.
- Disability accumulation in MS appears significantly influenced by aging, irrespective of disease classification.
- Further research into pathophysiologic mechanisms and external factors impacting MS is warranted.
Related Concept Videos
01:19Multiple Sclerosis l: Introduction
20
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
20
01:22Myasthenia Gravis ll: Pathophysiology
53
The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
53
01:27Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
948
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
948
01:25Secondary Spinal Cord Injury llI: Pathophysiology
52
Early Ischemia and Ionic ImbalanceWithin minutes of spinal cord injury, a secondary cascade begins, progressing over hours to weeks. Vascular damage reduces blood flow, causing ischemia and mitochondrial dysfunction. ATP depletion leads to ion pump failure, membrane depolarization, sodium influx, potassium efflux, and water accumulation, resulting in cellular swelling. Increased intracellular calcium further disrupts mitochondria and accelerates cellular injury.Excitotoxicity and Neuronal...
52
01:20Inflammatory Bowel Disease IV: Clinical Manifestations
33
Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The...
33
01:16Clinical Trials
8.5K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
8.5K